AU715663B2 - Improved medical containers - Google Patents

Improved medical containers Download PDF

Info

Publication number
AU715663B2
AU715663B2 AU27197/97A AU2719797A AU715663B2 AU 715663 B2 AU715663 B2 AU 715663B2 AU 27197/97 A AU27197/97 A AU 27197/97A AU 2719797 A AU2719797 A AU 2719797A AU 715663 B2 AU715663 B2 AU 715663B2
Authority
AU
Australia
Prior art keywords
container
container opening
stopper
autoclavable
fluid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU27197/97A
Other versions
AU715663C (en
AU2719797A (en
Inventor
Gunnar Andersson
Des Mulligan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fresenius Kabi AB
Original Assignee
Pharmacia and Upjohn AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn AB filed Critical Pharmacia and Upjohn AB
Publication of AU2719797A publication Critical patent/AU2719797A/en
Application granted granted Critical
Publication of AU715663B2 publication Critical patent/AU715663B2/en
Publication of AU715663C publication Critical patent/AU715663C/en
Assigned to FRESENIUS KABI AB reassignment FRESENIUS KABI AB Alteration of Name(s) in Register under S187 Assignors: PHARMACIA & UPJOHN AB
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10Bag-type containers

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Materials For Medical Uses (AREA)
  • Control And Other Processes For Unpacking Of Materials (AREA)
  • Devices For Use In Laboratory Experiments (AREA)
  • Glass Compositions (AREA)
  • Packages (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A sealed container opening, intended for fluid communication with a container for storing medical fluids, comprising a tubular sleeve-formed part (22, 22A) having a resilient pierceable stopper (24, 24A) inserted in its mouth (21, 21A) and a covering sealing device (10, 10A). The sealed container opening contains the same autoclavable polyolefinic material as the container. All parts of said container opening, exposed to the fluid or fluid handling devices are sterilized in a signal process by means of steam transferred to these parts during its autoclavation. Saddle formed port systems attachable to a flexible container are also disclosed.

Description

WO 97/39952 PCT/SE97/00682 Improved medical containers Field of invention The present invention relates to improved openings for medical containers, especially suitable for containers storing parenterally administerable fluids which preferably should be sterilized by steam after being finally assembled filled and sealed.
Background of the invention For manufacturers of parenteral fluids who wish to replace the traditional glass containers, it has been a highly demanding problem to find a polymeric material capable of withstanding autoclavation and yet be able to meet the often rigorous requirements set on its oxygen barrier and water vapor barrier capacities. Especially when sensitive fluids for use in parenteral nutrition, such as lipid emulsions containing long chain polyunsaturated fatty acids, amino acid solutions and carbohydrates shall be heat sterilized and stored for a long time, problems with oxygen induced degradation and incompatibility with the polymeric material, might lead to the appearance of potentially hazardous products. A solution to the problem of finding a suitable storage system comprising a flexible container filled with parenteral nutrients to replace glass bottles is demonstrated in the as yet unpublished Swedish patent application 9601348-7.
When manufacturing different types of containers of polymeric materials for storing parenterally administerable fluids, it has been a considerable problem to provide a suitable degree of sterility for all the parts of the container. It would also be highly desirable, for reasons of safety for the patients, for the convenience of hospital personal and for economical reasons to achieve and maintain a suitably high degree of sterility by means of a single steam sterilization process autoclavation) which is performed after the container has been finally assembled, filled and sealed.
Flexible containers for storage of parenteral nutrients are conventionally provided with ports for filling and dispensing of the nutrients. Tubular ports may be attached by means of welding when forming side seams, as performed in the International Patent WO 97/39952 PCT/SE97/00682 Application WO 95/26177 (Fresenius AG). Another manner of providing a flexible container with ports is disclosed in the above mentioned Swedish patent application 9601348-7, wherein a flexible polymer material is introduced in the form of sheets, to which a saddle formed port system comprising two separate ports is attached. When manufacturing such a container two holes are pressed in the sheet for the tubular ports, whereupon the saddle is welded to the sheet which is folded and welded to a bag shaped container by forming two side seams and a top seam. The container may be filled through the saddle formed port, or preferably by one or more temporary ports in connection to the welded seams before it is sterilized.
Conventional saddle-formed port systems normally comprise an additive port for the introduction to the container, just before administration, of a complementary perishable fluid, such as a solution of vitamins to a stored parenteral nutrient. It will also comprise a dispensing port for establishing a fluid connection between the container and the patient in need of fluid therapy. The ports are generally tube formed and often of a predetermined different size in order to clearly show their identity to the user.
The additive port is often sealed with a stopper made of latex rubber fitted in mouth of the port which can be penetrated by a needle. The dispensing port is typically formed with a membrane of polypropylene which can be pierced with a spike connected to the infusion device. The mouth of such a port is finally sealed before storage by a removable cap or a foil. These ports have a drawback in that the small space between the stopper and the sealing cap or foil will not be reached by sterilizing steam which constitutes a risk for contamination in connection with the penetration. To solve this problem, the saddle-formed port systems have either been presterilized by means of radiation before being assembled to the bags or alternatively a water droplet has been introduced in the small space to provide sterilizing vapor during the heat treatment. Both these solutions are unsatisfying, since they require either an extra sterilization routine by radiation which often might deteriorate the quality of polymeric materials or an extra water droplet adding routine. Whenever using this type of containers, the handling personnel at the hospitals are instructed to, as an extra safety routine, wipe the latex rubber with a disinfectant before piercing it with a needle connected to an infusion tubing.
The same problem is also present with the type of plastic bottle formed containers made with a "blow-fill-seal" method, as described in the Swedish patent application 9303 123-5. This type of bottles are sealed by a resilient stopper and a cap at the top of the bottle and finally sealed in the autoclave with a weak seal between the stopper and the inner surface of the container neck. The small space between the stopper and the cap will not be properly sterilized by steam unless a water droplet is introduced in a separate process. An incorrectly sterilized pierceable surface means a risk for contamination, especially when the containers are aimed for storage of several dosages and several collections of fluid will be made by piercing the stopper with a needle.
It would also be highly desirable to be able to recycle also a bag-formed container with an attached saddle-formed port system without a laborious dismembering and collection of different materials S" in separate processes, as being made possible with the containers, according to the mentioned the Swedish patent application 9303123-5.
The frequently used resilient latex stopper of the ports must be S individually collected from used bags before they can be recycled. The presence of any latex stoppers will effectively spoil a recycling process of polypropylene based bags. It would also be advantageous to benefit from the advantage of introducing sealing weak weldings with the final heat sterilization, as obtained between the container body or the cap and elastomeric sealing device in the mentioned Swedish patent application 9303123-5.
It would also be desirable to provide a saddle formed port system hrving ports which fit to high number of spike connections without leakage so they are compatible with a large number of infusion sets existing on the market. Especially dispensing ports sealed S36 with a polypropylene membrane, will often leak and are not sufficiently resealable after being pierced, while latex stoppers in addition ports have a drawbavk by their tendency to be unintentionally displaced from the mouth of the port. This type of sealing devices might also cause problems due to particles torn off when being penetrated.
V
P:\OPER\MKR\SPECI\27197-97.CLM 30/11/99 -4- According to the present invention it is intended to provide pierceable openings for medical containers which can overcome the above mentioned problems both in saddle port systems for bag formed containers and other types of containers or at least provide a viable alternative.
It is an object of the invention to provide a sealed opening for a medical container which is capable of being correctly sterilized by steam in all parts exposed to the fluid and fluid handling devices.
Other objects of the present invention will become apparent from the following description thereof.
Description of the invention *00090 S 15 The present invention is directed to container openings for fluid communication with a container for storing medical fluids, especially for parenteral administration. The container opening comprises a tubular sleeve-formed part with a resilient and pierceable stopper inserted in its mouth and a sealing device covering said mouth and stopper. The tubular sleeve-formed part, the stopper, and the sealing device contain, at least to a substantial amount, the same 20 polyolefinic material, so they can be recycled with same process in a recycling plant without being dismembered and separately collected after use. It is a characteristic feature of a sealed Scontainer opening according to the present invention that it can be heat sterilized by steam in a single process while all its parts, that will be exposed to, or come in contact with, either with the fluid directly or devices used for handling or transferring the fluid are sterilized by 25 means of direct contact with steam transferred to said parts during the autoclavation.
According to a first embodiment of the invention there is provided a sealed container opening, intended for fluid communication with a container for storing medical fluids, comprising a tubular sleeve-formed part having a resilient pierceable stopper inserted in its mouth and a covering sealing device, wherein said container opening contains the same S autoclavable polyolefinic material as the container characterized in that said covering sealing I 1 P:\OPER\MKR\SPECI\27197-97.CLM 30/11/99 device is in the form of a peelable foil capable of being penetrated by sterilizing steam, in order to sterilize the space between said foil and said stopper so that all parts of said container opening, exposed to the fluid or fluid handling devices are sterilized in a single process by means of steam transferred to said parts of the container opening during its autoclavation.
It is preferred, according to the invention, that the stopper further comprises a thermoplastic elastomer. Preferred polyolefin materials according to the invention are polypropylene and/or polyethene.
The present invention is also directed to an autoclavable container for storage of medical fluids having at least one of the aforedescribed container openings.
Detailed description of the invention 15 Fig. 1 shows an inventive saddle-formed port systems with two ports having openings according to the present invention.
U
3 S r
US
.3
U
S
SO S
S
S. S 00
S
0
I?
V WO 97/39952 PCT/SE97/00682 6 Fig. 2 is an enlargement of the steam transporting axial slit between the stopper and the tubular sleeve wall in one of the ports according to Fig. 1.
Fig. 3 shows an alternative embodiment of an opening according to the present invention.
Fig. 4 shows a saddle-formed port system having the alternative opening of Fig. 3 attached.
Fig. 1, shows a side view of an inventive saddle-port system with two openings for fluid communication with a container (not shown) constituted by the ports 20 and 20' which are of somewhat different size for easily identifying the dispensing and additive port, respectively. Both ports have sealed openings according to the present invention and are largely identical and consist of a generally cylindrical, tubular sleeves 22, 22' which preferably have slightly beveled part 23, 23' of a shape designed to fit various fluid transfer devices, such as a conventional spike-formed connections to an infusion device. It is particularly preferred to have such a shape that fits spikes according to the conventional ISO-standard.
A cylindrical resileint and pierceable stopper 24 is positioned in the mouth part 21 of the orifices by means of an insert device 25 which rests on an annular shelf 26. The stopper is made of a resilient thermoplastic elastomer and is designed to fit snugly and sealingly in the mouth. It is conceivable within the context of the present invention to find other suitable designs of the insert device and the annular shelf extended around the inner periphery of the tubular sleeves. The ports can be provided with a fingergrip portion 27 to give the user a more comfortable stability when inserting devices for fluid transfer into the port. The mouth of the opening is sealed with a cap formed sealing device 10 which is provided with a flange 11 fitted over the edge of the mouth. To obtain a safe sealing against the environment, the contact surface between the mouth and the cap formed sealing device can be welded together by, for example ultrasonic welding. The cap formed sealing device can also be provided with a preformed rupture line (not shown) which preferably is circular and will burst when it is twisted by the user to provide a WO 97/39952 PCT/SE97/00682 7 round aperture, through which a needle or spike can penetrate the stopper and establish fluid communication with the container.
As best demonstrated in Fig. 2, there is a small closed space extended between the cap formed sealing device and the upper face of the stopper which might never be reached by sterilizing steam from the inside of the container during the autoclavation process. As a result, the surface penetrated by a needle or a connecting spike might be contaminated due to an unsatisfying sterilization which at worst case will waste the fluids of the container and be hazardous for the patient.
This problem is solved with the present invnetion by the temporary formation of an axially extended annular slit 41 between the peripheral surface of stopper and the inner peripheral wall of the tubular sleeve of the orifice. The slit 41 opens for transportation of steam from the interior of the container to the closed space 40 during the autoclavation of the container. Such an axial slit is formed when the tubular sleeve expands more in a radial direction than the stopper during the heat treatment in the autoclave. When the container subsequently is cooled in the autoclave, the slit closes because of a comparable contraction of the stopper and the sleeve and a weak seal is formed in their contact surface.
The formation of a slit and the subsequent formation of a weak seal in the autoclave requires a careful selection of polymeric materials. To successfully obtain weak seals, it is important that the stopper contains a certain amount of a thermoplastic elastomer, such as a dispersed EPDM-rubber or SEBS (styrene-ethylene-butadienstyrene copolymer), so the stopper can exert a balancing pressure when tubular sleeve expands and contracts during the autoclavation process. A high compatibility between these parts are also required, because molecules must be exchanged in the contact surface of said parts, in order to form a weak seal. Both the stopper and the tubular orifice sleeve, should therefore contain the same polyolefinic material, in order to obtain such a molecular compatibility. This requirement that must also be set on the entire port system for enabling it to be recycled together with the rest of the container. The port system must, consequently, also be compatible with the material of the flexible container, so it can successfully be attached to it by means of welding during the assembly. Moreover, the stopper must have certain resilience to meet the requirements to obtain a weak welding, as well WO 97/39952 PCT/SE97/00682 8 as being resealable, so it can be penetrated several times and maintain the integrity of the container. It is also a requirement that the stopper material shall have a certain friction against the connection spike to prevent the spike to be unintentionally displaced from the stopper and to provide a sealing connection with a high number of different types of connecting spikes existing on the market.
A suitable material for the stopper is a polyolefin polymer which contains a thermoplastic elastomer. The same polyolefin must be present, both in the remaining parts of the port system and in the container. Suitable polyolefin materials are polyetylenes or polypropylene, their mixtures and copolymers of various medical grades. It has been shown in the present invention that it is surprisingly advantageous to have a high amount of polypropylene in the port system compatible with a polypropylene containing material in the containers.
For the stopper it is especially preferred to select materials of polypropylene containing a certain amount of a thermoplastic elastomer like Dynaflex® from GLS Corp. comprising polypropylene and SEBS. However other polypropylene based materials having comparable characteristics can be used in the present invention, such as those having dispersed particles of EPDM-rubber in the matrix like Santoprene® from Monsanto. A stopper made of such a material will also solve the problem with particles torn away as a result of its penetration and it has a high resealing capacity after a penetration.
The material of the remaining saddle-formed port system shall preferably be compatible with the material of the infusion bag in order enable a suitable attachment, for example by means of welding.
Both materials shall preferably contain the same polyolefinic material so they are capable of being recycled in the process and so a separate collection procedure is avoided. A suitable material for the bag formed infusion container is based on polyolefines, such as polyethylene or polypropylene, their mixture and copolymers. A preferred material is Excel® from McGaw Inc., generally described in the European patent 0228919.
Excel® has a multilayered structure substantially comprising: a) an inner, sealant layer facing the medical fluid consisting of a mixture of a polyethylene/polypropylene copolymer (FINA Dypro Z WO 97/39952 PCT/SE97/00682 9 9450) and Kraton® G1652 from Shell (a styrene/ethylene/butadien/styrene copolymer); b) a middle, tie layer of pure Kraton® G1652; and c) an outer, release layer of Ecdel® 9965 (or 9566 or 9967) from Eastman Kodak Co. which is a cycloaliphatic thermoplastic copolyester (a copoly(ester ether), a condensation product of the trans isomer of 1,4-dimethyl-cyclohexanedicarboxylate, of cyclohexanedimethanol and hydroxyterminated polytetramethylene glycol).
When using Excel® as the material for the bag formed container, the saddle formed port system suitable contains polypropylene and preferably consists of a mixture of polypropylene and Kraton® which is weldable to the inner layer of the Excel® film.
Suitable mixtures are in range of about 80 to 40% polypropylene and to 60% Kraton®. The polypropylene is of homogenous interpenetrating polymer network (IPN) quality, capable of forming weak seals at about 105 to 120 0 C, preferably at about 117°C and a permanent welding at about 160 0 C. However, the skilled person will have no difficulty in finding appropriate compositions of polypropylene and thermoplastic elastomer for the inventive port system and its constituents given the provisions set out above.
An alternative embodiment of a sealed opening to a medical container, according to the invention, is demonstrated in Fig. 3. This opening is suitable in the previously discussed saddle-formed port systems, has a generally cylindrical part 22A with a mouth 21A. A resilient and pierceable stopper 24A is sealingly positioned in the mouth and rests on the annular shelf 26A formed in said sleeve 22A.
The stopper 24A is made of a resilient pierceable material, suitably a polyolefin containing a certain amount of a thermoplastic elastomer and preferably Dynaflex® or a comparable material as disclosed above, while the other parts of the orifice preferably are made of polypropylene with mixtures of Kraton®, as also disclosed above. The opening is sealed before sterilization by a peelable foil 12A which is sealingly fitted over an annular outwardly extended protrusion 28A ol WO 97/39952 PCT/SE97/00682 WO 97/39952 PCT/SE97/00682 10 the mouth 21A. In order to be able to correctly steam sterilize all parts of the orifice including the connected filled container, steam must the transferred also to the upper surface 40A of the pierceable stopper 24A which shall be penetrated by a needle or a spike. A transfer of steam therefore must be arranged through the peelable foil in the autoclave, while the foil also must be capable of maintaining sterile conditions and prevent airborne or contact contamination of the surface during the subsequent storage. The material of the peelable foil must therefore be selected among steam permeable, but heat resistant materials which otherwise can form an effective sealing barrier for contaminating agents. Suitable materials are found among spun polyolefins, such as Tyvek® from DuPont and among certain qualities of lacquered papers.
As demonstrated in Fig. 4, this type of container opening is preferably connected to the mouth part of the generally cylindrically formed sleeves of a port of a saddle formed port system. To facilitate the connection to the sleeves, the outer peripheral surface of the cylindrical part 22A can be provided with an annular protrusion 29 which is intended to fit in a corresponding annular recess 29' provided in the inner peripheral surface of the sleeve formed port. These features will also enable the container opening to be safely fixed to the sleeve during the handling, in order to avoid it to be unintentionally dismembered when removing a spike or a needle penetrating the stopper.
The openings are manufactured in a process wherein the Dynaflex® is injected into a pre-shaped cylindrical opening by means of two-color mold injection machine, whereupon the foil is assembled in a separate process.
When using such a container opening for fluid transfer, the foil 12A will be removed by a simple peeling motion to expose the sterile upper pierceable surface 40A of the stopper which can immediately be pierced by a conventional connection spike or a comparable device for establishing fluid connection without a risk for contamination.
Besides the advantages stated above, the described sealed container openings and the saddle-formed port systems including them will, for many practical applications eliminate the use of a secondary, outer pouch wrapped over the bag-formed container during storage for standard solutions and other parenteral solutions.
P:\OPER\MKR\SPEC1\27197-97.CLM 30/11/99 11 even if certain oxygen sensitive products like amino acids and lipid emulsion will require additional protective measures.
It is also to be understood that the inventive container openings, not only shall be regarded as limited in use to saddle formed port systems connected to flexible bag-formed containers. They are equally useful as parts of a bottle shaped more rigid polymer container containing sensitive medical fluids which require autoclavation before storage.
The examples given, above, are intended to illustrate functioning embodiments of the present invention and shall not be regarded as limiting for the scope of the invention, as it is presented by the following set of claims.
Throughout this specification, unless the context requires otherwise, the word "comprise", or variations such as "comprises" or "comprising", will be understood to imply the 15 inclusion of a stated element or integer or group of elements or integers but not the exclusion of any other element or integer or group of elements or integers.
c.
.r
CCC
S
C
SC.
S
e g.
CC S CC S 0
S
CS 0 0
C
6 6 <fo^

Claims (8)

1. A sealed container opening, intended for fluid communication with a container for storing medical fluids, comprising a tubular sleeve-formed part having a resilient pierceable stopper inserted in its mouth and a covering sealing device, wherein said container opening contains the same autoclavable polyolefinic material as the container characterized in that said covering sealing device is in the form of a peelable foil capable of being penetrated by sterilizing steam, in order to sterilize the space between said foil and said stopper so that all parts of said container opening, exposed to the fluid or fluid handling devices are sterilized in a single process by means of steam transferred to said parts of the container opening during its autoclavation.
2. A container opening according to claim 1 characterized in that the polyolefinic material is polypropylene or polyethene, their mixtures or copolymers.
A container opening according to either claim 1 or 2 characterized in that the stopper further comprises a thermoplastic elastomer.
4. An autoclavable container for storage of medical fluids having at least one container opening according to any one of claims 1 to 3. *S
5. An autoclavable container according to claim 4 wherein said container can be recycled S* in a single process without being dismembered.
S6. An autoclavable container according to claim 5 having a flexible container body made •S of polyolefin containing multilayered material.
7. An autoclavable container according to claim 6 wherein said polyolefin is polypropylene. 7-- xu f. P:\OPfR\MKR\SPECI\27197-97.CLM 30/11/99 13
8. A sealed container opening and autoclavable containers having such openings, substantially as hereinbefore described with reference to the Figures. DATED this 30 th day of November, 1999 Pharmacia Upjohn AB By DAVIES COLLISON CAVE Patent Attorneys for the Applicants '3 guR 3 3~ 3 3, 333333 3 3 3 3.. 30 3 43 3. 3 3~333 3. 3. 3 3333 33 3* 3 3 33 6 03 33 *.330. 3 6 303333 3 0 3.. 3 II
AU27197/97A 1996-04-23 1997-04-23 Improved medical containers Ceased AU715663C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9601540 1996-04-23
SE9601540A SE9601540D0 (en) 1996-04-23 1996-04-23 Improved medical containers
PCT/SE1997/000682 WO1997039952A1 (en) 1996-04-23 1997-04-23 Improved medical containers

Publications (3)

Publication Number Publication Date
AU2719797A AU2719797A (en) 1997-11-12
AU715663B2 true AU715663B2 (en) 2000-02-10
AU715663C AU715663C (en) 2000-09-28

Family

ID=

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230231A (en) * 1979-04-16 1980-10-28 Coulter Electronics, Inc. Closure cap
US4297316A (en) * 1980-01-07 1981-10-27 Baxter Travenol Laboratories, Inc. Maintaining the dimensional integrity of thermoplastic tubing ends for receiving a luer
WO1995008317A1 (en) * 1993-09-24 1995-03-30 Pharmacia Ab Containers for medical fluids

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230231A (en) * 1979-04-16 1980-10-28 Coulter Electronics, Inc. Closure cap
US4297316A (en) * 1980-01-07 1981-10-27 Baxter Travenol Laboratories, Inc. Maintaining the dimensional integrity of thermoplastic tubing ends for receiving a luer
WO1995008317A1 (en) * 1993-09-24 1995-03-30 Pharmacia Ab Containers for medical fluids

Also Published As

Publication number Publication date
ZA973434B (en) 1997-11-19
JP2000508993A (en) 2000-07-18
NZ332178A (en) 2000-01-28
AU2719797A (en) 1997-11-12
NO318853B1 (en) 2005-05-18
NO984929D0 (en) 1998-10-22
DK0904234T3 (en) 2002-12-30
WO1997039952A1 (en) 1997-10-30
EP0904234A1 (en) 1999-03-31
DE69714992D1 (en) 2002-10-02
DE69714992T2 (en) 2003-01-02
CA2251267C (en) 2005-10-11
PT904234E (en) 2003-01-31
EP0904234B1 (en) 2002-08-28
ATE222871T1 (en) 2002-09-15
CA2251267A1 (en) 1997-10-30
NO984929L (en) 1998-12-15
SE9601540D0 (en) 1996-04-23
ES2183165T3 (en) 2003-03-16

Similar Documents

Publication Publication Date Title
US7527619B2 (en) Medical fluid container
JP3694317B2 (en) Port adapter and protector and container having them
US7717897B2 (en) Medical fluid container with concave side weld
US6039718A (en) Multiple use universal connector
US6179823B1 (en) Multiple use universal connector flexible medical container assembly
US6308847B1 (en) Medical containers
EP0554988B1 (en) Mixing apparatus
CZ326098A3 (en) Reservoir for parenteral liquids
JPH0518582B2 (en)
US20060276769A1 (en) Medical fluid container
EP0904234B1 (en) Improved medical containers
MX2010008304A (en) Closure cap for containers.
AU715663C (en) Improved medical containers
AU2007265010B2 (en) Medical fluid container
WO2016196632A1 (en) Package fitment comprising dual port
WO1999002119A1 (en) Improvements related to medical containers
JPH0975425A (en) Medical vessel
NO319718B1 (en) Process for the preparation of pharmaceutical closures
JPH09108302A (en) Medical container and its manufacture
JPH10328269A (en) Medical container
JPH07313572A (en) Infusion vessel
JPH10165479A (en) Medical container
JPH10314273A (en) Medical vessel
JPH0956779A (en) Mouth structure of medical container

Legal Events

Date Code Title Description
DA2 Applications for amendment section 104
FGA Letters patent sealed or granted (standard patent)
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS WAS NOTIFIED IN THE OFFICIAL JOURNAL DATED 20000217

PC Assignment registered

Owner name: FRESENIUS KABI AB

Free format text: FORMER OWNER WAS: PHARMACIA AND UPJOHN AB